Daiichi Sankyo
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
May, 2024
May 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Apr
Daiichi Sankyo
May 16, 2024, 16:51 |
Insight
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
In the fast-growing field of oncology, we are witnessing significant advances in several treatment modalities…
Apr 28, 2024, 11:19 |
Blog
Paolo Tarantino: Truly groundbreaking work that turned a failed chemotherapy in one of the most active anticancer drugs ever developed
Paolo Tarantino shared a post by Florian Muller, Co-Head of Biology at Powder Gate Discovery, on…
Apr 25, 2024, 12:59 |
Societies
Chitkala Kalidas: It was a pleasure participating in the industry panel discussion at Cancer Drug Development Forum
Chitkala Kalidas, Vice President, Global Head of Oncology at Bayer shared a post on LinkedIn:…
Apr 12, 2024, 05:16 |
Drugs
Tanja Obradovic: Era of antibody drug conjugates just got even more exciting with the first tumor-agnostic approval for ADC
Tanja Obradovic, Vice President of Oncology Scientific Affairs at ICON, recently shared on LinkedIn: "Era…
Mar 16, 2024, 14:58 |
Blog
Lung Cancer Research Foundation has announced three research grant awards funded by Daiichi Sankyo and AstraZeneca
Haichuan Hu, Director of Early Clinical Development - Hematology, Oncology and Cell Therapy at Bristol…
Jan 12, 2024, 17:07 |
Blog
Latest pharma industry updates by Nicolas Schmitz
Nicolas Schmitz, Senior Manager, Strategic Market Analyst at KBI Biopharma, shared a post on LinkedIn:…
Nov 18, 2023, 17:16 |
Blog
Leon 'Jun' T.: A few interesting observations from the top 25 antibody drug conjugates bone marrow deals
Leon 'Jun' T., Scientific Advisor at Mianus Capital, shared on LinkedIn: "Updated on 2023-11-10 by…
Aug 19, 2023, 18:15 |
Opinion
Rodney B. Smith: Why I believe in the potential of biomarkers.
Quoting Rodney B. Smith, the Vice President of the Global Oncology Medical Affairs Franchise Head…
All:
8
Posts:
1 - 10
10 Most Promising Cancer Drugs Not Yet Approved: Solid Tumors - 2024 edition by OncoDaily
Elie G. Dib: Excited to share the results of the TAPUR study
OncoInfluencers: Dialogue with Fadlo R. Khuri, hosted by Gevorg Tamamyan
Cedars-Sinai is co-chairing a special AACR conference on transforming the field of Bladder Cancer on May 17-20
Barbara Jereczek-Fossa has been elected as the ESTRO President-elect!
Facebook
RSS Feed
Twitter
Linkedin
Youtube